Search

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

Kyra Smerkanich represents clients in complex civil litigation, helping them to navigate the challenging landscapes that arise in business and insurance disputes. Working in partnership with her clients – with an eye towards understanding their business practices and legal needs – Kyra is not afraid...

Brandon Brauer's practice focuses primarily on commercial real estate transactions, including leases, purchases and sales, financings, construction contracts and condominium regime work. Brandon's experience includes single-asset and portfolio transactions with respect to multifamily properties...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

Brandon Sherman devotes his practice to advising institutions of higher education, accreditation agencies, and educational companies that support their missions. Drawing on a combination of legal experience from private practice and government roles at the U.S. Department of Education, Brandon’s...

Max Bremer advises entrepreneurs and established companies on key transactions throughout the business life cycle, from formations and financings to mergers, acquisitions and divestitures. Max works with clients in a variety of industries, including health care IT, medical devices, data analytics...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...